U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Posted inBiotechnology and Bioengineering Cancer China Cystic Fibrosis Delaware Drugs (Pharmaceuticals) Eli Lilly and Company Factories and Manufacturing GlaxoSmithKline PLC Government Contracts and Procurement House of Representatives Intellectual Property Janssen Pharmaceutica Labor and Jobs Leukemia Massachusetts People's Liberation Army (China) Research Senate Shortages Start-ups Supply Chain Tax Credits, Deductions and Exemptions United States International Relations United States Politics and Government

U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
TikTok Bill’s Progress Slows in the Senate
Posted inBeijing Bytedance Technology Co Ltd Blumenthal, Richard Computers and the Internet House of Representatives Law and Legislation Mergers, Acquisitions and Divestitures Mobile Applications Politics and Government Senate Social Media TikTok (ByteDance) United States International Relations United States Politics and Government

TikTok Bill’s Progress Slows in the Senate

Legislation to force TikTok’s Chinese owner to sell the app or have it banned in the United States sailed through the House, but the Senate has no plans to move hastily.